1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Antibiotic Resistance Market, By Disease
5.1 Introduction
5.2 Clostridium difficile infections
5.3 Hospital-acquired bacterial pneumonia
5.4 Complicated intra-abdominal infections
5.5 Community-acquired bacterial pneumonia
5.6 Acute bacterial skin and skin-structure infection
5.7 Bloodstream infection
5.8 Complicated urinary tract infections
6 Global Antibiotic Resistance Market, By Pathogen
6.1 Introduction
6.2 Baumannii
6.3 Pseudomonas aeruginosa
6.4 Enterococcus faecium
6.5 Hemophilus Influenzae
6.6 K. Pneumoniae
6.8 E. Coli
6.9 Streptococcus pneumoniae
6.10 Clostridium difficile
6.11 Staphylococcus Aureus
6.12 Acinetobacter
7 Global Antibiotic Resistance Market, By Drug Class
7.1 Introduction
7.2 Tetracyclines
7.3 Cephalosporins
7.4 Oxazolidinones
7.5 Combination therpaies
7.6 Lipoglycopeptides
7.7 Other Drug Classes
8 Global Antibiotic Resistance Market, By Mechanism of Action
8.1 Introduction
8.2 Cell Wall Synthesis Inhibitors
8.3 DNA Synthesis Inhibitors
8.4 Protein Synthesis Inhibitors
8.5 RNA synthesis inhibitors
8.6 Other Mechanism of ActionS
9 Global Antibiotic Resistance Market, By End User
9.1 Introduction
9.2 Hospitals & Clinics
9.3 Homecare
9.4 Research Organizations
9.5 Other End Users
10 Global Antibiotic Resistance Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 Basilea Pharmaceutica Ltd.
12.2 Tetraphase Pharmaceuticals, Inc.
12.3 Entasis therapeutics
12.4 Theravance Biopharma
12.5 Paratek Pharmaceuticals, Inc.
12.6 Seres Therapeutics
12.7 Merck & Co. Inc.
12.8 Achaogen Inc.
12.9 Melinta Therapeutics
12.10 AbbVie, Inc.
12.11 Johnson & Johnson
12.12 Pfizer Inc.
12.13 Cipla Ltd.
12.14 Bayer AG
12.15 AstraZeneca plc
12.16 Novartis AG
12.17 Teva Pharmaceutical Industries Ltd.
12.18 Roche Holding AG
12.19 Cubist Pharmaceuticals, Inc.
12.20 Mylan N.V.
List of Tables
Table 1 Global Antibiotic Resistance Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Antibiotic Resistance Market Outlook, By Disease (2021-2030) ($MN)
Table 3 Global Antibiotic Resistance Market Outlook, By Clostridium difficile infections (2021-2030) ($MN)
Table 4 Global Antibiotic Resistance Market Outlook, By Hospital-acquired bacterial pneumonia (2021-2030) ($MN)
Table 5 Global Antibiotic Resistance Market Outlook, By Complicated intra-abdominal infections (2021-2030) ($MN)
Table 6 Global Antibiotic Resistance Market Outlook, By Community-acquired bacterial pneumonia (2021-2030) ($MN)
Table 7 Global Antibiotic Resistance Market Outlook, By Acute bacterial skin and skin-structure infection (2021-2030) ($MN)
Table 8 Global Antibiotic Resistance Market Outlook, By Bloodstream infection (2021-2030) ($MN)
Table 9 Global Antibiotic Resistance Market Outlook, By Complicated urinary tract infections (2021-2030) ($MN)
Table 10 Global Antibiotic Resistance Market Outlook, By Pathogen (2021-2030) ($MN)
Table 11 Global Antibiotic Resistance Market Outlook, By Baumannii (2021-2030) ($MN)
Table 12 Global Antibiotic Resistance Market Outlook, By Pseudomonas aeruginosa (2021-2030) ($MN)
Table 13 Global Antibiotic Resistance Market Outlook, By Enterococcus faecium (2021-2030) ($MN)
Table 14 Global Antibiotic Resistance Market Outlook, By Hemophilus Influenzae (2021-2030) ($MN)
Table 15 Global Antibiotic Resistance Market Outlook, By K. Pneumoniae (2021-2030) ($MN)
Table 16 Global Antibiotic Resistance Market Outlook, By E. Coli (2021-2030) ($MN)
Table 17 Global Antibiotic Resistance Market Outlook, By Streptococcus pneumoniae (2021-2030) ($MN)
Table 18 Global Antibiotic Resistance Market Outlook, By Clostridium difficile (2021-2030) ($MN)
Table 19 Global Antibiotic Resistance Market Outlook, By Staphylococcus Aureus (2021-2030) ($MN)
Table 20 Global Antibiotic Resistance Market Outlook, By Acinetobacter (2021-2030) ($MN)
Table 21 Global Antibiotic Resistance Market Outlook, By Drug Class (2021-2030) ($MN)
Table 22 Global Antibiotic Resistance Market Outlook, By Tetracyclines (2021-2030) ($MN)
Table 23 Global Antibiotic Resistance Market Outlook, By Cephalosporins (2021-2030) ($MN)
Table 24 Global Antibiotic Resistance Market Outlook, By Oxazolidinones (2021-2030) ($MN)
Table 25 Global Antibiotic Resistance Market Outlook, By Combination therpaies (2021-2030) ($MN)
Table 26 Global Antibiotic Resistance Market Outlook, By Lipoglycopeptides (2021-2030) ($MN)
Table 27 Global Antibiotic Resistance Market Outlook, By Other Drug Classes (2021-2030) ($MN)
Table 28 Global Antibiotic Resistance Market Outlook, By Mechanism of Action (2021-2030) ($MN)
Table 29 Global Antibiotic Resistance Market Outlook, By Cell Wall Synthesis Inhibitors (2021-2030) ($MN)
Table 30 Global Antibiotic Resistance Market Outlook, By DNA Synthesis Inhibitors (2021-2030) ($MN)
Table 31 Global Antibiotic Resistance Market Outlook, By Protein Synthesis Inhibitors (2021-2030) ($MN)
Table 32 Global Antibiotic Resistance Market Outlook, By RNA synthesis inhibitors (2021-2030) ($MN)
Table 33 Global Antibiotic Resistance Market Outlook, By Other Mechanism of ActionS (2021-2030) ($MN)
Table 34 Global Antibiotic Resistance Market Outlook, By End Users (2021-2030) ($MN)
Table 35 Global Antibiotic Resistance Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
Table 36 Global Antibiotic Resistance Market Outlook, By Homecare (2021-2030) ($MN)
Table 37 Global Antibiotic Resistance Market Outlook, By Research Organizations (2021-2030) ($MN)
Table 38 Global Antibiotic Resistance Market Outlook, By Other End Users (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
